Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 Growth Companies With Insider Ownership As High As 26%

In This Article:

As global markets navigate a landscape marked by interest rate adjustments and mixed economic signals, growth stocks have continued to outperform their value counterparts, particularly in the technology sector. Amidst these shifts, insider ownership can serve as a compelling indicator of confidence in a company's potential to thrive; companies with significant insider stakes often signal strong alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

People & Technology (KOSDAQ:A137400)

16.4%

37.3%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.3%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Seojin SystemLtd (KOSDAQ:A178320)

30.9%

39.9%

Medley (TSE:4480)

34%

31.7%

Laopu Gold (SEHK:6181)

36.4%

34.2%

Brightstar Resources (ASX:BTR)

16.2%

84.5%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

131.1%

HANA Micron (KOSDAQ:A067310)

18.5%

110.9%

Findi (ASX:FND)

34.8%

112.9%

Click here to see the full list of 1529 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

RaySearch Laboratories

Simply Wall St Growth Rating: ★★★★★☆

Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer care across various regions including the Americas, Europe, Africa, the Asia-Pacific, and the Middle East, with a market cap of SEK7.03 billion.

Operations: The company generates revenue of SEK1.17 billion from its healthcare software segment.

Insider Ownership: 23.6%

RaySearch Laboratories has demonstrated strong growth, with earnings increasing by 172.8% over the past year and expected to grow 24.1% annually, outpacing the Swedish market's forecasted growth of 14.6%. Recent client orders from major institutions like Institut Curie and GenesisCare UK underscore its expanding market presence. The recent appointment of a new CFO suggests strategic leadership changes as it continues leveraging its high insider ownership to drive innovation in oncology treatment planning systems.

OM:RAY B Earnings and Revenue Growth as at Dec 2024
OM:RAY B Earnings and Revenue Growth as at Dec 2024

Surgical Science Sweden

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of approximately SEK7.88 billion.